(Press-News.org) The COVID-19 pandemic has highlighted health disparities for people of color, who have been disproportionately affected by the pandemic. People with opioid use disorder (OUD) faced unique challenges when many mental health and addiction services were forced to scale back operations or temporarily close when social distancing guidelines were put in place.
A group of researchers in the College of Agriculture, Health and Natural Resources recently published their findings in the Journal of Substance Abuse and Treatment about the experiences of racial-ethnic minorities during the COVID-19 pandemic among people with OUD.
Doctoral candidate Colleen Mistler, professor Michael Copenhaver, and assistant professor Roman Shrestha, all from the Department of Allied Health Sciences, collaborated with colleagues at Yale University and Drexel University, as well as the UConn Institute for Collaboration on Health, Intervention and Policy (InCHIP) on this research.
This population was of particular interest to the research group, since people with OUD and of a racial/ethnic minority group are particularly vulnerable to COVID-19 and its adverse health outcomes. Additionally, the group was already working with this population on studies related to improving HIV and substance use prevention outcomes as part of research efforts led by Copenhaver and Shrestha.
"As the pandemic unfolded, experts started raising concerns about both the direct and indirect impacts of COVID-19 on people with OUD," Shrestha says.
The researchers distributed a survey to 110 patients taking medication for opioid use disorder - methadone in this sample - to treat opioid addiction. They asked respondents about their substance use, sexual behavior, mental health, economic impacts of the pandemic, and experience with COVID-19 and preventative measures. The researchers collected their data from May 2020 through June 2020.
This broad range of variables allowed the researchers to craft a more expansive view of the pandemic's impact on participants' lives.
"We wanted to see the whole picture of how it was affecting the individual," Mistler says.
The researchers found people of color were more likely to know someone who died from COVID-19, and were more likely to be concerned about COVID-19. Racial-ethnic minorities also reported more difficulty accessing COVID-19 testing than white participants.
The researchers also found increases in depression, anxiety, and frustration across all groups during the pandemic, which has cut many people off from friends and family due to social distancing and travel restrictions.
Participants of color reported greater reductions in substance use behavior during the pandemic than white participants, which was a positive finding for the researchers.
Respondents did not report changes in number of sexual partners or how often they have unprotected sex, which raises concerns about contracting COVID-19 as well as sexually transmitted infections, like HIV.
"When you're supposed to be social distancing, you still want those behaviors to change, to reduce. And a majority of people didn't change those behaviors," Mistler says.
The group published another paper, on which Mistler is the lead author, in the Journal of Community Health, highlighting how the pandemic led to a reduction in the proportion of people in this population taking pre-exposure prophylaxis (PrEP), a drug that protects against HIV infection. However, they did not find any significant reduction in people getting tested for HIV.
The researchers found participants were still accessing methadone treatment. The clinics they sampled from, including the syringe services program, in the New Haven area established services such as telehealth, mobile-clinics, take-home bottles of methadone, and remained open at a safely limited capacity.
"The continued availability of these services, although in a limited capacity, were really helpful, and may be the reason why we're not seeing a significant difference in the use of addiction treatment and HIV prevention services," Shrestha says.
These findings will hopefully guide clinics in serving their patients using innovative strategies, such as telehealth and mobile clinics, during the current, and future, public health crises.
"These are essential services we should definitely advocate for," Mistler says.
INFORMATION:
The Middle East and North Africa Region (MENA) is a climate change hot spot where summers warm much faster than in the rest of the world. Some parts of the region are already among the hottest locations globally. A new international study predicts that ignoring the signals of climate change and continuing business-as-usual will lead to extreme and life-threatening heatwaves in the region. Such extraordinary heat events will have a severe impact on the people of the area.
The study, which aims at assessing emerging heatwave characteristics, was led by scientists from the Climate and Atmosphere Research Center (CARE-C) of The Cyprus Institute and the Max Planck Institute for Chemistry, with the contribution of researchers from the CMCC Foundation - Euro-Mediterranean ...
People with certain blood types are more likely to have blood clots or bleeding conditions, kidney stones, or pregnancy-induced hypertension, suggests a study published today in eLife.
The study confirms previously identified connections between certain blood types and the risk of blood clots and bleeding, and makes a new connection between kidney stones and having type B blood as compared to O. The discoveries may lead to new insights on how a person's blood type may predispose them to developing a certain disease.
Previous studies have found that people with blood type A or B were more likely to have cardiovascular disease or experience ...
TROY, N.Y. -- When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.
Published this week in Cell Reports, this finding -- from Gaetano Montelione, a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute, and his collaborators at the Icahn School of Medicine at Mount Sinai and the University of Texas at Austin -- raises the potential for repurposing available drugs as COVID-19 antivirals in cases where a vaccine isn't practical or effective.
Remdesivir, which blocks viral replication by interfering with a viral polymerase, must ...
ADELPHI, Md. -- Army researchers developed a technique that allows robots to remain resilient when faced with intermittent communication losses on the battlefield.
The technique, called α-shape, provides an efficient method for resolving goal conflicts between multiple robots that may want to visit the same area during missions including unmanned search and rescue, robotic reconnaissance, perimeter surveillance and robotic detection of physical phenomena, such as radiation and underwater concentration of lifeforms.
Researchers from the U.S. Army Combat Capabilities Development Command, known as DEVCOM, Army Research Laboratory and the University of Nebraska, Omaha ...
In a uniquely deep and detailed look at how the commonly used anesthetic propofol causes unconsciousness, a collaboration of labs at The Picower Institute for Learning and Memory at MIT shows that as the drug takes hold in the brain, a wide swath of regions become coordinated by very slow rhythms that maintain a commensurately languid pace of neural activity. Electrically stimulating a deeper region, the thalamus, restores synchrony of the brain's normal higher frequency rhythms and activity levels, waking the brain back up and restoring arousal.
"There's a folk psychology or tacit assumption that what anesthesia does is simply 'turn off' the brain," said ...
Ecologists at the University of Cologne's Institute of Zoology have for the first time demonstrated the enormously high and also very specific species diversity of the deep sea in a comparison of 20 deep-sea basins in the Atlantic and Pacific Oceans. Over a period of 20 years, a research team led by Professor Dr Hartmut Arndt at the Institute of Zoology has compiled a body of data that for the first time allows for a comparison of the diversity of existing eukaryotes - organisms with a cell nucleus. Sediment samples from depths of 4000 to 8350 meters, ...
Tokyo, Japan - Human T-cell lymphotropic virus type-1 (HTLV-1) is a retrovirus similar to human immunodeficiency virus (HIV) and has mostly been thought to be transmitted vertically (mother-to-child), or horizontally (sexually or parenterally (e.g. via blood transfusion)). The spread of this infection in metropolitan areas such as Tokyo is presumed to be due to horizontal transmission, especially sexual transmission.HTLV-1-associated diseases are thought to be caused mainly through vertical transmission. In a new study, clinicians from Tokyo Medical and Dental University (TMDU) describe that horizontal transmission route ...
Most conventional molecular diagnostics usually detect only a single disease-related biomarker. Great examples are the PCR tests currently used to diagnose COVID-19 by detecting a specific sequence from SARS-CoV-2. Such so-called singleplex methods provide reliable results because they are "calibrated" to a single biomarker. However, determining whether a patient is infected with a new SARS-CoV-2 variant or a completely different pathogen requires probing for many different biomarkers at one time.
Scientists from the Helmholtz Institute for RNA-based ...
PHILADELPHIA (April 27, 2021) - Nurses and other clinicians rely heavily upon the electronic health record (EHR) to provide patient care. This includes clinical decision-making, care planning, patient surveillance, medication ordering and administration, and communication with other health care team members. While data show that EHR technology usability can put added burden on clinicians, the relationships between EHR usability and the job outcomes of hospital staff nurses and surgical patient outcomes have not been explored.
A new study from the University of ...
A combination of remdesivir, a drug currently approved in the United States for treating COVID-19 patients, and repurposed drugs for hepatitis C virus (HCV) was 10 times more effective at inhibiting SARS-CoV-2, the virus that causes COVID-19.
The combination therapy points a way toward a treatment for unvaccinated people who become infected, as well as for vaccinated people whose immunity has waned, for example due to the emergence of virus variants that escape this immune protection.
Four HCV drugs--simeprevir, vaniprevir, paritaprevir, and grazoprevir--in combination with remdesivir boosted the efficacy of remdesivir by as much as 10-fold, the researchers reported today in Cell Reports. The research team included scientists from Icahn School of Medicine at Mount Sinai, the ...
